Counterpoint: Does the Risk of E-Cigarettes Exceed Potential Benefits? No | Medpage Today
"The appeal of e-cigarettes to tobacco cigarette smokers should be enhanced, through the development of nicotine delivery kinetics that replicate those of the addictive but lethal tobacco cigarettes. Finally, e-cigarettes should be placed at an economic advantage by heavily taxing tobacco cigarettes but not e-cigarettes.
Most importantly, the deceptive combusted-cigarette industry must not be entrusted with any aspect of e-cigarette development or marketing, without unceasing, highly critical, and comprehensive oversight."
Holly R. Middlekauff, MD is Professor of Medicine (cardiology) and Physiology at the University of California Los Angeles. She received her BS in molecular chemistry and biophysics from Yale University, her MD from the USC School of Medicine and did her internal medicine internship and residency, as well as her cardiology fellowship at UCLA.
She has some great credentials!
"The appeal of e-cigarettes to tobacco cigarette smokers should be enhanced, through the development of nicotine delivery kinetics that replicate those of the addictive but lethal tobacco cigarettes. Finally, e-cigarettes should be placed at an economic advantage by heavily taxing tobacco cigarettes but not e-cigarettes.
Most importantly, the deceptive combusted-cigarette industry must not be entrusted with any aspect of e-cigarette development or marketing, without unceasing, highly critical, and comprehensive oversight."
Holly R. Middlekauff, MD is Professor of Medicine (cardiology) and Physiology at the University of California Los Angeles. She received her BS in molecular chemistry and biophysics from Yale University, her MD from the USC School of Medicine and did her internal medicine internship and residency, as well as her cardiology fellowship at UCLA.
She has some great credentials!